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Abstract
Background: The requirement for ultrasound to establish gestational age among women seeking abortion can be
a barrier to access. Last menstrual period dating without clinical examination should be a reasonable alternative
among selected women, and if reliable, can be task-shared with non-clinicians. This study determines the accuracy
of gestational age estimation using last menstrual period (LMP) assessed by community health care workers (CHWs)
, and explores providers’ and CHWs’ perspectives on task sharing this activity. The study purpose is to expand
access to early medical abortion services.
Methods: We conducted a multi-center cross-sectional study at four urban non-governmental reproductive health
clinics in South Africa. CHWs interviewed women seeking abortion, recorded their LMP and gestational age from a
pregnancy wheel if within 63 days. Thereafter, providers performed a standard examination including ultrasound to
determine gestational age. Lastly, investigators calculated gestational age for all LMP dates recorded by CHWs. We
compared mean gestational age from LMP dates to mean gestational age by ultrasound using t-tests and calculated
proportions for those incorrectly assessed as eligible for medical abortion from LMP. In addition, in-depth interviews
were conducted with six providers and seven CHWs.
Results: Mean gestational age was 5 days (by pregnancy wheel) and 9 days (by LMP calculation) less than ultrasound
gestational age. Twelve percent of women were eligible for medical abortion by LMP calculation but ineligible by
ultrasound. Uncertainty of LMP date was associated with incorrect assessment of gestational age eligibility for medical
abortion (p = 0.015). For women certain their LMP date was within 56 days, 3% had ultrasound gestational ages >70 days.
In general, providers and CHWs were in favour of task sharing screening and referral for abortion, but were doubtful that
women reported accurate LMP dates. Different perspectives emerged on how to implement task sharing gestational age
eligibility for medical abortion.
Conclusions: If LMP recall is within 56 days, most women will be eligible for early medical abortion and LMP can
substitute for ultrasound dating. Task sharing gestational age estimation is feasible in South Africa, but its implementation
should meet women’s privacy needs and address healthcare workers’ concerns on managing any procedural risk.
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Plain English summary
Medical abortion was introduced in 2011 in South
Africa, is very effective and safe for abortion up to 9
weeks and does not require specialized surgical skills.
However, introductory protocols required an ultrasound
examination be done to date the pregnancy using equip-
ment and expertise not widely available, especially in
more remote rural areas. If women can remember the
first day of their last menstrual period (LMP), this can
be used to work out their pregnancy duration, and if
community health workers (CHWs) can ascertain
pregnancy duration from women’s LMP, this could assist
expansion of medical abortion services into primary care
public health facilities across the country.
This study identified women for whom LMP dating
would suffice to ensure a safe and effective medical
abortion, and gauged nurses’ and CHWs’ opinions on
how they could share responsibility for this activity.
CHWs recorded LMP among women seeking abortion at
reproductive health clinics in South Africa, and pregnancy
duration was calculated. Thereafter, providers performed an
ultrasound examination. Proportions were calculated for
women incorrectly assessed as eligible for medical abortion
from LMP overall, and according to different LMP cut-off
dates. Providers and CHWs were also interviewed.
A small percentage (3%) of women underestimated
their LMP such that the chances of continuing a preg-
nancy may increase and women may experience more
side effects. In general, providers and CHWs favored
sharing responsibility for establishing gestational age
eligibility for medical abortion, but were doubtful that
women reported accurate LMP dates. They also had
different perspectives on ways to implement this. Future
implementation of task sharing gestational age estima-
tion for medical abortion should meet women’s privacy
needs as well as health-care workers’ concerns about
possible health risks.
Background
Abortion on request in the first trimester of pregnancy
was made legal in South Africa in 1997, and mifepris-
tone for medical abortion was approved for use in med-
ical abortion by the South African drug regulatory
authority in 2001. The combined regimen of mifepris-
tone and misoprostol has been available in the private
sector since 2001 and in the public sector, where the
majority of women access healthcare, since 2010 [1].
Medical abortion for women with pregnancies up to 9
weeks' gestational age has gradually been introduced
into primary care public sector health facilities around
the country, however expansion of the service has been
slow, in part due to a scarcity of trained providers, and
rural districts are generally underserved [2]. Access has
been limited to facilities or referral centers that have
ultrasound equipment and the requisite expertise as the
2010 provincial medical abortion guidelines [1] mandated
the use of ultrasound to determine gestational age eligibil-
ity for all abortion procedures – in contrast to other more
recent recommendations where routine use of pre-
abortion ultrasound is not an absolute requirement [3] and
may be substituted with bimanual clinical examination [4].
Medical abortion involves taking pills, and the require-
ment for an ultrasound assessment of gestational age
can create a significant barrier since providing the medi-
cation and the information to safely and effectively take
it is simple and well documented. Simplifying gestational
age assessment could have a major impact on access and
service delivery in a range of contexts, particularly at
primary care level. If gestational age based on last
menstrual period (LMP) can be accurately assessed by
community health care workers (CHWs) in supportive
roles, this could potentially reduce delays though appro-
priate referral to facilities, improve access and save
women’s and providers’ time. In addition, this approach
could save healthcare resources in other ways such as
not buying unnecessary equipment or requiring services
of a trained sonographer.
The requirement for an ultrasound examination is a
barrier to abortion access in many resource-limited
settings and researchers have long challenged this pre-
requisite [5–7]. More recently the accuracy of LMP-based
gestational age has again been under review [8] with
efforts to identify criteria that would ensure a safe and
effective medical abortion in terms of a woman’s
gestational age, using LMP rather than ultrasound [9]. An
earlier study from South Africa found that LMP-based
gestational age was accurate on average, compared to
ultrasound dating, but that there were high levels of
uncertainty among 12% of women [6]. Other published
studies demonstrated better accuracy of LMP-based
gestational age estimations [9], suggesting that LMP recall
may vary according to country context [5, 7, 9, 10]. It is
also evident that LMP recall is more difficult for women
with irregular menstrual cycles [11] and that recall can be
significantly biased among women seeking abortion when
the pregnancy is advanced [12]. Calculation of gestational
age from LMP to the current date has been aided by the
use mechanical pregnancy wheels (2 concentric discs with
dials on their perimeters, the upper one able to rotate),
however electronic calculators have been shown to be
more accurate as they involve less user-error [13, 14].
To expand access to medical abortion where barriers
exist due to the ultrasound requirement and provider
shortages, the most recent WHO guidelines [15] recom-
mend task-shifting LMP-based gestational age estima-
tion to lay health workers or for women to evaluate this
themselves. The research evidence guiding these recom-
mendations suggests task sharing this component of care
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could be safe and feasible for abortion in the first trimes-
ter where services are often offered in primary care
settings, but cautions that further rigorous contextual
research is needed in this regard. Similar recommenda-
tions were made with respect to self-assessment of
gestational age for medical abortion eligibility by women
themselves [15].
This study analyzes data from a larger multi-country
validation study of a medical abortion eligibility checklist
tool for use by CHWs as a means to improve access to
medical abortion though expansion of the scope of the
CHWs' roles [16]. In this sub-study we present evidence
on the effectiveness of CHWs' assessment of gestational
age among women seeking abortion and provider
opinion on task sharing this activity. We compare three
methods of gestational age estimation: 1) LMP plus
digital calculation by investigators of intervening days
for gestational age estimation, 2) LMP plus pregnancy
wheel used by CHWs for gestational age estimation, and
3) gestational age from ultrasound examination by clini-
cians. In addition, we describe providers’ and CHWs’
perspectives on task sharing eligibility assessment for
medical abortion. The purpose of the study is to advance
the potential for gestational age eligibility for medical
abortion to be performed by CHWs or by women
themselves, without the need for ultrasound examin-
ation, in order to expand access to medical abortion
services in South Africa.
Methods
Study participants and setting
Women were recruited between August and October,
2012 in urban sexual and reproductive health clinics
providing abortion in Kwazulu-Natal (three clinics) and
the Western Cape (one clinic). The sample size calcu-
lated for the parent study was based on the assumption
that 60% of women seeking abortion would be eligible
for medical abortion. To achieve a two-sided 90% confi-
dence interval for 60% ±15% sensitivity and 80% ±15%
specificity, it was estimated a sample size of 211 was
needed [16]. The project was conducted at non-
governmental organization (NGO) clinics with providers
(nurse clinicians) trained in medical abortion as well as
certified CHWs in counselling roles; at the time no
public sector service was able to meet these require-
ments. For this study, CHWs received 2 days of didactic
training on the menstrual cycle, abortion methods and
eligibility, and use of the pregnancy wheel.
Study procedures
Gestational age assessments
Women seeking abortion at study clinics were
approached by a research assistant to determine interest
and eligibility. Eligibility criteria were: 18 years or older,
able to speak local languages, and willing and able to
give written informed consent. Eligible women provided
written consent, completed a socio-demographic ques-
tionnaire with the research assistant, and were inter-
viewed by CHWs using the medical abortion assessment
toolkit developed for the parent study. CHWs recorded
known or estimated LMP with the aid of a calendar
when needed, used the pregnancy wheel to establish
eligibility for medical abortion based on gestational age,
and recorded the gestational age from the wheel if
within 63 days. Thereafter women were seen by a
provider who completed a standard clinical examination
protocol including an ultrasound examination for
eligibility for medical abortion and recorded these data.
None of the women had been informed of their gesta-
tional age prior to joining the study, and the CHWs
were masked as they interviewed women prior to them
seeing the clinician.
Analysis of gestational age assessments
The main outcome was the difference between LMP-
based gestational age estimates and ultrasound-based
gestational age. Two methods of LMP-based gestational
age were included in this analysis; firstly, from CHWs'
estimate of gestational age using the pregnancy wheel
(only recorded where wheel gestational age was within
63 days - referred to as GA by wheel), and secondly, by
investigator post-hoc calculation of gestational age based
on recorded LMP date (referred to as GA by calculation)
for all participants. Mean LMP-based gestational age
(LMP-based GA) estimations were compared to ultra-
sound gestational age (U/S GA) using paired t-tests and
Bland Altman plots. For each of the LMP-based
methods we calculated the proportion of cases in the
caution zone, described as those with an LMP-based GA
within 63 days, but with U/S GA beyond 63 days [5].
Conflicting classifications of cases into the caution zone
using the pregnancy wheel compared to the digital cal-
culation were identified and described. Potential associa-
tions for being in the caution zone and for being unsure
of LMP date were assessed using Kruskal-Wallis and
Chi-squared tests for continuous and categorical vari-
ables respectively. Following the approach in recently
published literature [9], we then calculated the propor-
tion of women whose GA by calculation was either <=56
or <=63 days but for whom U/S GA was beyond 63 days
or 70 days. Subgroups in this analysis included women
who stated they were sure of their LMP date.
In-depth interviews
In-depth interviews (IDIs) were done with all CHWs
and providers who had assessed at least six women in
the quantitative study when data collection for gesta-
tional age assessment was complete. Following informed
Constant et al. Reproductive Health  (2017) 14:100 Page 3 of 8
consent, interviews were conducted by an experienced
study investigator in English, according to a semi-
structured interview guide. IDIs were recorded and tran-
scribed, and stripped of personal identifiers. Transcripts
were analyzed using a thematic approach based on the
interview guide.
All participants in the study provided written informed
consent and their confidentiality was safeguarded.
Women received ZAR50 reimbursement on conclusion
of their participation in the study for any expenses in-
curred; providers and CHWs were not reimbursed for
participating in the IDIs. The study protocol was ap-
proved by the World Health Organization Research Eth-
ics Review Committee and the University of Cape
Town’s Human Research Ethics Committee.
Results
Gestational age assessments
Between August and October 2012, 236 women were
enrolled. Of these, 11 were excluded from this analysis
(Fig. 1) leaving 225 pairs with complete data; three had a
negative pregnancy test according to the CHW, two did
not see the clinician, three did not have pregnancies
confirmed by ultrasound, and three did not have an
ultrasound examination due to disruptions in clinic
routines.
There were 94 participants from the Western Cape
and 131 from KwaZulu-Natal (Table 1). Significant dif-
ferences in demographic or reproductive characteristics
between the two regions included a higher percentage of
women from the Western Cape with prior abortions,
with paid work, who used a contraceptive method in the
past year and who were not sure of their LMP as re-
corded by the CHW.
CHWs established known or estimated LMP date for
all 225 participants. Using the pregnancy wheel,
gestational age was within 63 days and was recorded by
the CHW for 170/225 (76%), and gestational age from
LMP calculated for all 225 participants, which included
those with later gestations. Mean LMP-based GA by
wheel for the subset of 170 participants (47 days,
SD = 9.3) was 9 days shorter than U/S GA (56 days,
SD = 17.2; p < 0.001) and for all participants, mean
LMP-based GA by calculation (56 days, SD = 17.7 days)
was 5 days shorter than U/S GA (61 days, SD = 21.3;
p < 0.001).
Bland-Altman plots illustrating the difference between
LMP GA and U/S GA against average gestational age
are shown in Fig. 2. The limits of agreement (GA by
wheel = −39 to 22 days; GA by calculation = −42 to
31 days) were wide for both methods. The plots demon-
strate increasing underestimation using LMP-based GA
as the pregnancy progresses, which was more prominent
for GA by wheel than for GA by calculation.
LMP GA by wheel allocated 31/170 (18%) and GA by
calculation allocated 28/225 (12%) to the caution zone.
Where there was conflicting classification into the cau-
tion zone by GA by wheel compared to GA by calcula-
tion, four cases were underestimated by 3 to 6 days and
one case by 30 days using the wheel compared to the
calculation. In contrast, two cases were overestimated
using the wheel and classified as ineligible so not in the
caution zone, but were eligible according to calculation
from LMP. Further analysis of the caution zone using
the LMP GA by calculation results showed that most
(22/28; 79%) had gestational ages between 9 and
12 weeks. Of the six cases with a gestational
age > 12 weeks, three were unsure of their LMP, all had
prior pregnancies, and none spoke English as their home
language (English home language was uncommon
among all participants; 31/225, 13.8%).
The only significant association with being in the
caution zone was uncertainty of LMP date. Three partici-
pants did not know their LMP date, while 28 were unsure
of this date. Combining “not sure” and “don’t know”, the
association with being in the caution zone was significant
for GA by wheel (p < 0.001), and for GA by calculation
(p = 0.015). By definition, women with later U/S GA were
more likely to be in the caution zone. No significant
associations with being in the caution zone were found for
age, home language, employment status, marital status,
numbers of previous pregnancies or any previous
abortions, use of any contraceptive method in the past
year, use of an injectable contraceptive in the last year; nor
were there any significant associations by province,
community health worker or by clinician. There were no
significant associations with being unsure of LMP other
than increasing gestational age (p = 0.035).
Table 2 shows proportions of participants with U/S
GA beyond 63 days according to two cut-offs of LMP-
Fig. 1 Flow chart of participants enrolled into the study
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based GA: Those with LMP <=56 days prior and those
with LMP <=63 days prior. A sub-analysis is included
for participants who stated they were sure of their LMP.
From these findings, of the women reporting their LMP
as within 63 days, 18% would have received a medical
abortion at U/S GAs >63 days, (Table 2). For those “sure”
of their LMP, this would have been 14%. However, of the
women reporting LMP dates as within 56 days,
10% would have received a medical abortion at U/S
GAs of >63 days and for those sure of their LMP, this
proportion decreased to 7%. Of this 7%, 4% had U/S GAs
of <70 days, and of the remaining 3%, all had U/S GAs be-
yond 75 and within 84 days (data not shown).
In depth interviews
We conducted interviews with six of the 10 providers (3
completed <6 assessments, 1 was unavailable) and seven
of the eight CHWs (1 completed only 3 assessments).
All four clinics were represented. On average, providers
were 29 years (SD: 7 years) and CHWs were 40 years
old (SD: 15 years). There was one male provider and one
male CHW, all had completed their high school
Table 1 Socio-demographic and reproductive characteristics of participants
Western Cape (n = 94) Kwazulu/Natal (n = 131) Total (n = 225) p-valuea
Age, (years)
Median (IQR) 26 (23.0-31.3) 26 (23.2-29.3) 26.0 (23.0-30.0) 0.452
School education, (years)
Completed school education
(Grade 12) (Yes) n (%)
66 (70.2) 92 (70.2) 158 (70.2) 1.000
Paid employment (Yes) n (%) 63 (67.0) 31 (33.0) 94 (40.9) <0.001
Previous pregnancies, n (%) 0.868
0 20 (21.3) 31 (23.7) 51 (22.7)
1 30 (31.9) 43(32.8) 73 (32.4)
2+ 44 (46.8) 57 (43.5) 101 (44.9)
Prior abortion (among those
ever pregnant) n (%)
21/74 (27.3) 10/100 (10.0) 31/17 (17.2) 0.003
Used contraception in last
year (Yes) n (%)
78 (83.0) 60 (45.8) 138 (61.3) <0.001
Sure of LMP date (Yes) n (%) 73 (77.7) 121 (92.4) 194/225 (86.2) 0.002
a Chi-squared tests for comparing categories, Kruskal-Wallis test for comparing medians
Fig. 2 Bland Altman plots comparing LMP-based GA with U/S GA
Table 2 Gestational ages for subgroups of women by LMP and
by Ultrasound
Gestational age All participants Participants
“sure” of LMP
N with LMP and U/S GA recorded 225 194
n (%) GA ≤ 63 days by U/S 152/225 (67.6) 140/194 (72.2)
N with GA ≤ 63 days by LMP 159 143
n (%) GA ≤ 63 days by U/S 131/159 (82.4) 123/143 (86.0)
N with GA ≤ 56 days by LMP 128 118
n (%) GA ≤ 63 days by U/S 115/128 (89.8) 110/118 (93.2)
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education. Providers had between 2 and 10 years’
experience and CHWs between 10 months and 3 years’
experience working in the health sector.
Acceptability of task sharing medical abortion eligibility
assessment
Providers were supportive of the notion of task sharing
assessment of women’s eligibility for medical abortion,
but saw this process as preliminary screening prior to re-
ferral to the clinician for a clinical assessment. They saw
the role of CHWs as confined to counselling and provid-
ing information on the abortion procedure as they be-
lieved women did not accurately report their LMP dates.
In addition, they felt problems between staff and confu-
sion for women could arise if there were conflicts be-
tween CHW’s and clinician’s estimates of gestational age
and eligibility for an abortion.
“Ultimately a professional clinician should assess
gestational age” (Centre manager, NGO).
CHWs were generally positive about their role in
assessing eligibility for medical abortion. They were in
agreement with providers that women were inaccurate
with their LMP dates, but had a number of suggestions
for ways of helping women recalling their LMP more ac-
curately. Some CHWs felt reassured that a clinical exam
would still be performed after their assessment, particu-
larly for women who experienced menstrual irregularity.
CHWs were familiar with pregnancy tests and easily
followed the questions on the study form. Some found
the pregnancy wheel problematic initially, although com-
petency improved with practice.
Implementing task sharing of medical abortion eligibility
assessment
There were discrepancies between providers and CHWs
and lack of agreement on a service delivery model for
implementation of task sharing. Providers expressed
some concerns about lack of supervision and account-
ability for CHWs, and that CHWs might provide infor-
mation outside their scope of practice. In contrast,
CHWs were enthusiastic about expanding their skills.
Providers felt it would be most beneficial for CHWs to
proactively perform eligibility assessments and provide
information within the community, while preserving
confidentiality, rather than at the clinic. However, CHWs
felt the clinic was a better place for this due to lack of
privacy in their usual encounters with community, which
were either group discussions or home visits. Ideas for
alternative placements for CHWs to conduct assessment
and provide information included government clinics,
hospitals and universities, while schools and homes were
not considered advisable due to stigma around abortion
and confidentiality concerns. Individual assessment and
referral could be done telephonically or in a private
place following a group information session.
Discussion
This clinic-based study compared LMP-based GA to an
ultrasound exam to determine the potential for screen-
ing gestational age eligibility for medical abortion by
CHWs or by women themselves using LMP recall. The
study found that on average, differences were slightly
larger than other studies in which clinicians use LMP
date to estimate gestational age among women seeking
abortion [5, 6, 8]. Use of the pregnancy wheel contrib-
uted to error, with 7/31 (23%) misclassifications with
respect to the caution zone using the pregnancy wheel
compared to a calculation from LMP date. The preg-
nancy wheel has been reported elsewhere as prone to
inaccuracies and use of electronic pregnancy calculators
is considered superior to manual calculations in clinical
settings [13, 14]. Recently, online electronic pregnancy
calculators for mobile phones have become readily avail-
able, are accurate and easier for women and CHWs to
use, with a pregnancy wheel for back-up and in settings
where this is not feasible [17].
GA by calculation allocated 12% to the caution zone,
which is similar to earlier studies conducted in the
United States (US) and South Africa [5, 6]. Uncertainty
of LMP date was the only significant association with
being in the caution zone in this study. While little con-
clusive evidence has been published on predictors for
being in the caution zone [5, 6, 12], being unemployed,
primigravidity, pregnancy denial and failure to recognize
pregnancy signs have been associated with inaccuracies
in estimation of pregnancy duration [5, 18].
Of importance is the proportion of women who would
be classified as eligible for medical abortion according to
their LMP but whose U/S GA is beyond the safety and
efficacy limits for medical abortion. Recent research
[19–22] has demonstrated that 200 mg mifepristone
combined with home-administered misoprostol is safe
and effective for medical abortion up to 70 days gesta-
tional age, and may be so up to 84 days, if women are
given additional misoprostol, as well as sufficient coun-
selling and support. In this study, only 3% of women
who were sure that their LMP date was at least 56 days
prior would have had a medical abortion beyond the 70-
day limit. This is more than the 0.6% for US women in
2011, but less than the earlier study (7.8%) of US women
in 2000 [9]. Currently in South Africa, medical abortion
with off-site use of misoprostol is permitted up 63 days
gestational age, however extending the medical abortion
gestational age limit to 70 days and task sharing gesta-
tional age eligibility decisions to CHWs or to women
themselves would result in a safe medical abortion for
most women who state that their LMP is within 56 days.
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For example, of 1000 women seeking abortion and
giving an LMP date no longer than 56 days earlier: If
assessed by a CHW, 970 would be managed safely and
effectively and 30 might need an additional intervention
such as additional misoprostol or an aspiration
procedure.
Fourteen percent of women stated they were uncertain
or did not know their LMP date, as compared with the
US (29%) and the United Kingdom (9.5%) [8]. The asso-
ciation between certainty of LMP and accuracy of LMP
date is be expected. For women who are unsure of their
LMP, additional prompts could help women reach a
closer approximation. Irregular menses and absence of a
personal calendar record or any significant event (e.g.
birthday) have been shown to hinder LMP recall [23].
The IDIs showed health care worker’s concerns with
respect to women’s ability to accurately report their
LMP. However, these concerns appear to be unwar-
ranted for women who recall their LMP to be within
56 days, with a degree of certainty. Recognizing this, the
recent guidelines for medical abortion (Canada) state
that ultrasound is not needed to determine gestational
age eligibility where women are sure of their LMP [24].
Recall is usually vaguer over longer periods of time
and discrepancies between LMP based GA and U/S GA
increase at later gestational ages [5, 9, 12, 18]. In
addition, a higher likelihood of underestimating gesta-
tional age among women seeking abortion compared to
women planning to take the pregnancy to term has been
reported [12]. However, in this study CHWs did not
often evaluate women in the second trimester as eligible
for early medical abortion – most women with advanced
pregnancies were likely to be correctly identified by
CHWs as requiring referral to centers providing second
trimester services.
In South Africa and in many other middle-income
countries, medical abortion up to 63 days gestational age
is provided at broad-based primary care level, while vac-
uum aspiration is done for gestations up to 84 days, but
is often only available at urban hospitals. Thus screening
and referral by CHWs, either community or facility-
based, has potential to save women’s time and reduce
delays by referring her directly to an appropriate facility
that will provide her with an abortion method of her
choice and at first visit. As LMP for gestational age
estimation is self-reported information, it may become
commonplace for women to use an online pregnancy
calculator based on LMP to self-assess whether they are
eligible for medical abortion. As such, our findings con-
tribute to the growing body of evidence supporting novel
service delivery models in which women are able to
safely use medical abortion without the involvement of a
healthcare intermediary. Self-management or task shar-
ing of gestational age assessment could relieve pressure
from providers, and pave the way for increased access to
medical abortion particularly in under-resourced facil-
ities where U/S is not available. For women not eligible
or not wanting a medical abortion, providers skilled in
bimanual pelvic examination can safely determine gesta-
tional age eligibility for first trimester abortions involv-
ing vacuum aspiration.
Study limitations included limited generalizability due
to the selection of NGO health services for the study
and that CHWs received specific training. We did not
ask women whether they had regular menstrual cycles,
which might be a significant factor determining accurate
recall of LMP. Further investigation into women’s per-
spectives on their own assessment of gestational age, or
how they feel about task sharing this component of care
with other cadres of healthcare providers is warranted.
Sustained and broad-based implementation of task shar-
ing would require careful planning and should meet
women’s privacy needs, address health-care workers’
concerns on managing procedural risk and include train-
ing, support and certification for CHWs. In addition, the
concerns of providers with respect to their clinical do-
main need to be addressed during this process.
Conclusions
In South Africa, if gestational age calculated from LMP is
within 56 days, this would ensure a safe and effective med-
ical abortion is provided in most cases. If unsure of their
LMP, and for those with further advanced pregnancies,
women would be advised to seek more specialized
services. If signs of a failed procedure or excessive bleed-
ing are explained to women and additional care is readily
available if needed, task sharing or self-assessment of
gestational age from LMP could expand access and
strengthen medical abortion services at primary care level.
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